These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Diagnosis and treatment protocols of cutaneous melanoma: latest approach 2010. Petrescu I; Condrea C; Alexandru A; Dumitrescu D; Simion G; Severin E; Albu C; Albu D Chirurgia (Bucur); 2010; 105(5):637-43. PubMed ID: 21141087 [TBL] [Abstract][Full Text] [Related]
30. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients. Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514 [TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for survival in malignant melanoma of the eyelid skin. Esmaeli B; Wang B; Deavers M; Gillenwater A; Goepfert H; Diaz E; Eicher S Ophthalmic Plast Reconstr Surg; 2000 Jul; 16(4):250-7. PubMed ID: 10923972 [TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging. Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant therapy in melanoma. Part I: Background, chemotherapy, radiation, and nonspecific immunotherapy. Elias EG Md Med J; 1990 May; 39(5):489-90. PubMed ID: 2185395 [No Abstract] [Full Text] [Related]
34. [Melanoma]. Saida T Gan To Kagaku Ryoho; 2006 Oct; 33(10):1386-91. PubMed ID: 17033225 [TBL] [Abstract][Full Text] [Related]
35. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291 [TBL] [Abstract][Full Text] [Related]
36. [Initial evaluation, diagnosis, staging, treatment, and follow-up of patients with primary cutaneous malignant melanoma. Consensus statement of the Network of Catalan and Balearic Melanoma Centers]. Mangas C; Paradelo C; Puig S; Gallardo F; Marcoval J; Azon A; Bartralot R; Bel S; Bigatà X; Curcó N; Dalmau J; del Pozo LJ; Ferrándiz C; Formigón M; González A; Just M; Llambrich A; Llistosella E; Malvehy J; Martí RM; Nogués ME; Pedragosa R; Rocamora V; Sàbat M; Salleras M Actas Dermosifiliogr; 2010 Mar; 101(2):129-42. PubMed ID: 20223155 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant irradiation for axillary metastases from malignant melanoma. Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890 [TBL] [Abstract][Full Text] [Related]
38. [Results of adjuvant therapy with the preparation Poly-a Poly-u in patients with malignant melanoma during a 10-year observation]. Pawlicki M; Jońca M; Krzemieniecki K; Zuchowska-Vogelgesang B Wiad Lek; 1993 Dec; 46(23-24):912-4. PubMed ID: 7900387 [TBL] [Abstract][Full Text] [Related]
39. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications]. Kruit WH; Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325 [TBL] [Abstract][Full Text] [Related]
40. [Combined and complex treatment of patients with II-stage malignant skin melanoma using hyperthermia]. Zhavrid EA; Fradkin SZ; Bezruchko VI; Firmanchuk AV; Proleskovskiĭ AK Vopr Onkol; 1986; 32(3):52-7. PubMed ID: 3962258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]